Is there a generic drug for Verzenio? A Look at Patents, Exclusivity, and Future Availability
•
3 min read
Verzenio, with the active ingredient abemaciclib, was first approved by the FDA in September 2017 to treat certain types of breast cancer. This groundbreaking medication is currently only available as a brand-name drug, which prompts many patients to ask: **Is there a generic drug for Verzenio?**.